Search research articles
Contact Us
Filters
Showing results (71-80 of 162) with videos related to
Page
of 17
Sort By:
Frontiers in Oncology
|
April 16, 2026
Glioblastoma and PARP inhibitors: the importance of patient selection to maximize therapeutic benefits. A critical review
Giovanni Dima, Vincenzo Di Nunno, Marta Aprile, et al.
Oncotarget
|
July 14, 2016
Sex-specific clinicopathological significance of novel (Frizzled-7) and established (MGMT, IDH1) biomarkers in glioblastoma
Salveena Schiffgens, Ludwig Wilkens, Alba A Brandes, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 24, 2021
Association between socioeconomic status and survival in glioblastoma: An Italian single-centre prospective observational study
Alicia Tosoni, Lidia Gatto, Enrico Franceschi, et al.
Virchows Archiv : an International Journal of Pathology
|
October 28, 2008
Gene expression profiling in glioblastoma and immunohistochemical evaluation of IGFBP-2 and CDC20
Gianluca Marucci, Luca Morandi, Elisabetta Magrini, et al.
Cancer
|
June 11, 2009
Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status
Alba A Brandes, Enrico Franceschi, Alicia Tosoni, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 18, 2026
Association of proton pump inhibitor use with outcome of patients with recurrent glioblastoma
Emilie Le Rhun, Debaleena Sain, Martin van den Bent, et al.
Biomedicines
|
January 8, 2025
Targeting Mitochondria in Glioma: New Hopes for a Cure
Lidia Gatto, Vincenzo Di Nunno, Anna Ghelardini, et al.
Neuroimage. Clinical
|
January 6, 2026
Individualized functionnectome for the statistical assessment of white matter circuits underlying task-fMRI activations in glioma patients
Giovanni Sighinolfi, Alexander Leemans, David Neil Manners, et al.
Journal of Neuro-Oncology
|
April 20, 2018
Third-line therapy in recurrent glioblastoma: is it another chance for bevacizumab?
Enrico Franceschi, Giuseppe Lamberti, Alexandro Paccapelo, et al.
Clinical Case Reports
|
August 30, 2021
Distinct MRI pattern of "pseudoresponse" in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review
Lidia Gatto, Enrico Franceschi, Alicia Tosoni, et al.
Page
of 17
Search research articles
Search
Showing results (71-80 of 162) with videos related to
Sort By:
Page
of 17
Frontiers in Oncology
|
April 16, 2026
Glioblastoma and PARP inhibitors: the importance of patient selection to maximize therapeutic benefits. A critical review
Giovanni Dima, Vincenzo Di Nunno, Marta Aprile, et al.
Oncotarget
|
July 14, 2016
Sex-specific clinicopathological significance of novel (Frizzled-7) and established (MGMT, IDH1) biomarkers in glioblastoma
Salveena Schiffgens, Ludwig Wilkens, Alba A Brandes, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 24, 2021
Association between socioeconomic status and survival in glioblastoma: An Italian single-centre prospective observational study
Alicia Tosoni, Lidia Gatto, Enrico Franceschi, et al.
Virchows Archiv : an International Journal of Pathology
|
October 28, 2008
Gene expression profiling in glioblastoma and immunohistochemical evaluation of IGFBP-2 and CDC20
Gianluca Marucci, Luca Morandi, Elisabetta Magrini, et al.
Cancer
|
June 11, 2009
Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status
Alba A Brandes, Enrico Franceschi, Alicia Tosoni, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 18, 2026
Association of proton pump inhibitor use with outcome of patients with recurrent glioblastoma
Emilie Le Rhun, Debaleena Sain, Martin van den Bent, et al.
Biomedicines
|
January 8, 2025
Targeting Mitochondria in Glioma: New Hopes for a Cure
Lidia Gatto, Vincenzo Di Nunno, Anna Ghelardini, et al.
Neuroimage. Clinical
|
January 6, 2026
Individualized functionnectome for the statistical assessment of white matter circuits underlying task-fMRI activations in glioma patients
Giovanni Sighinolfi, Alexander Leemans, David Neil Manners, et al.
Journal of Neuro-Oncology
|
April 20, 2018
Third-line therapy in recurrent glioblastoma: is it another chance for bevacizumab?
Enrico Franceschi, Giuseppe Lamberti, Alexandro Paccapelo, et al.
Clinical Case Reports
|
August 30, 2021
Distinct MRI pattern of "pseudoresponse" in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review
Lidia Gatto, Enrico Franceschi, Alicia Tosoni, et al.
Page
of 17